As companies develop a strategy that is both affordable and differentiated without being squeezed in the middle? Describes how to Teva, Israel first and largest multinational, globally reached its dominant position in the common pharmaceuticals, an industry that has undergone significant changes over the last 20 years. Considering strategies to protect themselves from low cost competitors from India and other emerging markets, as well as Big Pharma companies that are more aggressive tactics in genetics. "Hide
by Tarun Khanna, Krishna G. Palepu, Claudine Madras Source: HBS Premier Case Collection 28 pages. Publication Date: September 18, 2006. Prod. #: 707441-PDF-ENG
Related Case Solutions & Analyses:
Mobile C.A.R.E.
Sino-Forest (B)
Ace Social Venture Fund: Estimating Social Value Creation
Charles Schwab in 2002 Spreadsheet Exercise
Saras Options
Fsas: Fujitsu Support and Service Inc.
Porcini’s Pronto: “Great Italian cuisine without the wait!”
Cola Wars: Going Global
HOUSE OF QUALITY AT APPLE
UBS-ROGUE TRADER SCANDAL
